{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:48:00Z","timestamp":1789015680493,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.ejca.2011.10.018","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T15:24:49Z","timestamp":1321543489000},"page":"1700-1706","source":"Crossref","is-referenced-by-count":65,"title":["Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin\u2019s lymphoma \u2013 An Anglo-French collaborative report"],"prefix":"10.1016","volume":"48","author":[{"given":"Ananth","family":"Shankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina W.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Gorde-Grosjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hasenclever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lambilliotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Daw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Perel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Lejars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Coulomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Odile","family":"Oberlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Hamish","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Landman-Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2011.10.018_b0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00043426-200205000-00010","article-title":"Lymphocyte-predominant Hodgkin disease in children","volume":"24","author":"Sandoval","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2011.10.018_b0010","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1200\/JCO.2003.01.079","article-title":"Lymphocyte-predominant Hodgkin\u2019s lymphoma in children: therapeutic abstention after initial lymph node resection \u2013 a Study of the French Society of Pediatric Oncology","volume":"21","author":"Pellegrino","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2011.10.018_b0015","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/00043426-200309000-00003","article-title":"Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents","volume":"25","author":"Murphy","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ejca.2011.10.018_b0020","doi-asserted-by":"crossref","unstructured":"Shankar A, Daw S, Gorde-Grosjean S, et al. Treatment of children and adolescents with early stage nodular lymphocyte predominant Hodgkin\u2019s lymphoma with a low intensity short duration chemotherapy regimen [CVP] \u2013 on behalf of the EuroNet-PHL. Group ASH abstract # 2471; 2006.","DOI":"10.1182\/blood.V108.11.2471.2471"},{"key":"10.1016\/j.ejca.2011.10.018_b0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MOP.0b013e328013c89e","article-title":"Long-term effects of treatments for childhood cancers","volume":"19","author":"Alvarez","year":"2007","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.ejca.2011.10.018_b0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijrobp.2008.04.067","article-title":"Subsequent malignancies in children treated for Hodgkin\u2019s disease: associations with gender and radiation dose","volume":"72","author":"Constine","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2011.10.018_b0035","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/JCO.2009.24.0945","article-title":"Early-stage, lymphocyte-predominant Hodgkin\u2019s lymphoma: patient outcomes from a large, single-institution series with long follow-up","volume":"28","author":"Chen","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2011.10.018_b0040","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1200\/JCO.2009.24.8062","article-title":"Second malignant neoplasms in survivors of pediatric Hodgkin\u2019s lymphoma treated with low-dose radiation and chemotherapy","volume":"28","author":"O\u2019Brien","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2011.10.018_b0045","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM198801283180404","article-title":"Nodular and diffuse types of lymphocyte predominance Hodgkin\u2019s disease","volume":"318","author":"Regula","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2011.10.018_b0050","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/oxfordjournals.annonc.a059244","article-title":"Nodular type of lymphocyte predominant Hodgkin\u2019s disease: a clinical study of 50 cases","volume":"6","author":"Pappa","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2011.10.018_b0055","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1200\/JCO.1997.15.9.3060","article-title":"Clinical presentation and outcome in lymphocyte-predominant Hodgkin\u2019s disease","volume":"15","author":"Bodis","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2011.10.018_b0060","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/(SICI)1096-911X(199712)29:6<519::AID-MPO1>3.0.CO;2-N","article-title":"Lymphocyte predominant Hodgkin disease: clinico-pathologic features and results of treatment \u2013 the Pediatric Oncology Group experience","volume":"29","author":"Karayalcin","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ejca.2011.10.018_b0065","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","article-title":"Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin\u2019s disease and lymphocyte-rich classical Hodgkin\u2019s disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin\u2019s Disease","volume":"17","author":"Diehl","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2011.10.018_b0070","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2141.2007.06736.x","article-title":"Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma \u2013 a Children\u2019s Cancer and Leukaemia Group report","volume":"138","author":"Hall","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2011.10.018_b0075","first-page":"1860","article-title":"Report of the Committee on Hodgkin\u2019s disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2011.10.018_b0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cncr.22762","article-title":"Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma","volume":"110","author":"Mauz-K\u00f6rholz","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2011.10.018_b0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00259-010-1619-6","article-title":"18F-FDG PET\/CT in paediatric lymphoma: comparison with conventional imaging","volume":"38","author":"London","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejca.2011.10.018_b0090","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1200\/JCO.2008.19.7814","article-title":"Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin\u2019s lymphoma: analysis of a prospective multicenter trial","volume":"27","author":"Furth","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2011.10.018_b0095","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3324\/haematol.11661","article-title":"18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin\u2019s disease","volume":"93","author":"Ansquer","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.ejca.2011.10.018_b0100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/10428190601179783","article-title":"Comparison of (18)F flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma","volume":"48","author":"Mody","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejca.2011.10.018_b0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.coc.0000092701.47861.81","article-title":"German Hodgkin Lymphoma Study Group. The HD12 panel of the German Hodgkin Lymphoma Study Group (GHSG): a quality assurance program based on a multidisciplinary panel reviewing all patients\u2019 imaging","volume":"27","author":"Eich","year":"2004","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejca.2011.10.018_b0110","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ijrobp.2003.08.033","article-title":"German Hodgkin Study Group. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin\u2019s disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group","volume":"58","author":"Eich","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2011.10.018_b0115","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1080\/10428190600573291","article-title":"High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin\u2019s lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only","volume":"47","author":"van Grotel","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejca.2011.10.018_b0120","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/1097-0142(19830615)51:12<2293::AID-CNCR2820511221>3.0.CO;2-X","article-title":"Hodgkin\u2019s disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin\u2019s lymphomas","volume":"51","author":"Miettinen","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2011.10.018_b0125","first-page":"242","article-title":"Cellular origin of nodular lymphocyte-predominant Hodgkin\u2019s lymphoma: immunophenotypic and molecular studies","volume":"36","author":"Chan","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1016\/j.ejca.2011.10.018_b0130","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1080\/1042819031000149421","article-title":"Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group","volume":"45","author":"Huang","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejca.2011.10.018_b0135","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24819","article-title":"Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group","volume":"116","author":"Biasoli","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2011.10.018_b0140","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/00000478-199107000-00008","article-title":"Simultaneous lymphocyte predominant Hodgkin\u2019s disease and large-cell lymphoma","volume":"15","author":"Grossman","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2011.10.018_b0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1470-2045(05)70092-9","article-title":"Fertility preservation for young patients with cancer: who is at risk and what can be offered?","volume":"6","author":"Wallace","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2011.10.018_b0150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JCO.2006.08.4772","article-title":"Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin\u2019s disease","volume":"25","author":"Donaldson","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804911008252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804911008252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T17:25:29Z","timestamp":1593278729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804911008252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0959804911008252"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2011.10.018","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}